Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Touchlight’s z- dbDNA™ Technology Selected for Groundbreaking Gene Therapy Clinical Study
Thursday, October 16, 2025Touchlight a leader in synthetic DNA manufacturing announced today the use of its proprietary z dbDNA technology as a critical starting material in the manufacture of a cuttingedge gene therapy in a USbased clinical study
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros’ clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
Thursday, October 16, 2025Novo Nordisk and Omeros Corporation today announced that they have entered into a definitive asset purchase and license agreement for the candidate drug zaltenibart formerly OMS in clinical development
Quotient Sciences and Biorasi Partner to Accelerate Early Phase Clinical Trials to Patient Proof of Concept
Wednesday, October 15, 2025Quotient Sciences a leading global drug development research and manufacturing accelerator and Biorasi a global clinical research organization CRO today announced a strategic partnership to deliver fully integrated early phase clinical trial solution...
Hinge Bio Announces FDA Clearance of Investigational New Drug Application for HB2198, a Novel B cell-Depleting Agent, for Patients with Systemic Lupus Erythematosus and Lupus Nephritis
Tuesday, October 14, 2025Hinge Bio Inc a privatelyheld biotechnology company engaged in the discovery and development of innovative multispecific medicines announced the US Food and Drug Administration FDA has cleared the companys
Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio
Friday, October 10, 2025Novo Nordisk today announced that it has entered into a definitive agreement to acquire Akero Therapeutics Inc Akero a publicly held clinicalstage company developing innovative treatments for patients with serious
Santhera Secures Agreement with Biomedica for the Distribution of AGAMREE® (Vamorolone) in Russia
Friday, October 10, 2025Santhera Pharmaceuticals SIX SANN announces the signing of an exclusive agreement with Biomedica for the distribution of AGAMREE vamorolone in Russia for the treatment of Duchenne muscular
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
Thursday, October 09, 2025Lisata Therapeutics Inca clinicalstage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases and Catalent Inc Catalent
Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development
Wednesday, October 08, 2025Oragenics a clinicalstage biotechnology company developing braintargeted therapeutics through proprietary intranasal delivery technology today announced a strategic collaboration with ReceptorAI
AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX®) for the Treatment of Upper Limb Essential Tremor
Tuesday, October 07, 2025AbbVietoday announced positive topline results from the Phase ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA BOTOX compared to placebo for the treatment of upper limb essential tremor
RoosterBio and Secretome Therapeutics Announce Successful Completion of Large Scale Bioreactor Production for Clinical Stage Cell Therapy Candidate STM-01
Tuesday, October 07, 2025RoosterBio Inc a leading supplier of human mesenchymal stemstromal cells MSCs highly engineered media and bioprocess development services and Secretome Therapeutics a clinicstage company developing
